Impact of Physicians’ Awareness of Prostate-Specific Antigen Doubling Time (PSADT) on Treatment (Tx) Decisions in High-Risk (HR) Biochemically Recurrent (BCR) Prostate Cancer (PC)
Morgans AK, Touya M, El-Chaar N, ElSouda D, Ramaswamy K, Adejumo KL, Gentile D, Feinberg B, Asgarisabet P, Pathak P, Freedland SJ
ASCO GU 2025
- 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2025
| 肿瘤 | 前列腺癌 | 泌尿系统肿瘤
Clinical Characterization and Treatment Patterns in Patients With Metastatic Hormone-Sensitive Prostate Cancer at Three Third-Level Centers of the Mexican Institute of Social Security: A Retrospective Cohort Study
Rivera SR, Martínez-Valdez L, Cuéllar M, Medrano-Sánchez J, Méndez ACS, Oropeza G, Garcìa IAR, Velasco R, Gutiérrez S, Acevedo-Ibarra JN, Ruíz B, Rivas I, Tarrés MMZ
ASCO GU 2025
- 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2025
| 肿瘤 | 前列腺癌 | 泌尿系统肿瘤
Barriers to and Facilitators of First-Line Treatment Intensification (TI) in Metastatic Castration-Sensitive Prostate Cancer (mCSPC) by Practice Setting and Intensification Frequency: A Sub-Analysis of IMPLEMENT
Agarwal N, Loeb S, El-Chaar N, de Ruiter L, Kim J, Mack J, Thompson B, Rich-Zendel S, Sheldon J, Joo JS, Dyson J
ASCO GU 2025
- 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2025
| 肿瘤 | 前列腺癌 | 泌尿系统肿瘤
Homologous Recombination Repair Mutation Testing Patterns in Metastatic Castration-Resistant Prostate Cancer: Analysis of Real-World Data in the United States
Barata P, Amin S, Niyazov A, Kirker M, Ribbands A, Butcher J, Skilling J, Busby A, Hinds A, Castro E
ASCO GU 2025
- 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2025
| 肿瘤 | 前列腺癌 | 泌尿系统肿瘤 | 泰泽纳
Health-Related Quality of Life in Patients With Metastatic Prostate Cancer: Results From an International Real-World Survey
Castro E, Amin S, Niyazov A, Kirker M, Ribbands A, Butcher J, Walley M, Munir M, Barata P
ASCO GU 2025
- 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2025
| 肿瘤 | 前列腺癌 | 泌尿系统肿瘤 | 泰泽纳
